Research & Development



  沒听說過,打過之後再認識也不晚……   樹上的肥烏鴉不知為何鼓噪起來,呱呱的叫著,不安的在樹枝上皮球般的跳躍不休。超碰在公开线视频免费   劉據一下子就來了興趣,走到霍光身邊,圍著他轉了一圈,霍光也跟著轉,就是不讓他看見自己哭過的樣子。超碰97   “誰管什麼奴隸了,快睡覺!”   雲瑯搖搖頭道︰“直到現在也不見張安世回來安排後續事宜,說明他們那一邊進行的並不順利,應該是小光發現了什麼。這時候還不能撤退,撤退就是要退潮啊,到時候,誰先露出水面,誰的屁股就會暴露在光天化日之下。小光年紀小,個子矮,還能在水里待一會。”超碰视频在线观看   “你說狄山也不喜歡你?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo